Informed refusal: the patient's influence on long-term treatment.
D000533:Altruism; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D026686:Beneficence; D002908:Chronic Disease; D003657:Decision Making; D030881:Disclosure; D004992:Ethics, Medical; D005260:Female; D005610:Freedom; D006801:Humans; D007258:Informed Consent; D008134:Long-Term Care; D016743:Mental Competency; D001523:Mental Disorders / Q000628:therapy*; D028642:Persons with Psychiatric Disorders; D008875:Middle Aged; D010045:Outpatients; D010076:Oxazepam / Q000627:therapeutic use; D026706:Paternalism; D010361:Patients; D026684:Personal Autonomy; D010820:Physicians; D011619:Psychotropic Drugs; D011788:Quality of Life; D012008:Recurrence; D012306:Risk; D018570:Risk Assessment; D012559:Schizophrenia / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D016312:Treatment Refusal
Mental Health Therapies; Professional Patient Relationship